StockData
BioRestorative Therapies, Inc. logo

BioRestorative Therapies, Inc. (BRTX) stock

BRTXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 14, 2026Score 8/30
$1.34−0.08 (-5.63%)

Close on Nov 17, 2026Market cap $34.14MP/E –Yield –

BioRestorative Therapies price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

BioRestorative Therapies's price to sales ratio was 111.1× on Nov 11, 2026, against 382.3× a year earlier. Over the last 4 years it ranged from 1.2× to 493.3×, with a median of 49.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 2026111.1×−377.9
2025Dec 31, 2025489.0×+438.8
2020Jul 31, 202050.2×+31.6
2019Dec 31, 201918.7×−407.9
2016Apr 29, 2016426.6×−49.9
2015Dec 31, 2015476.4×+434.9
2014Dec 31, 201441.5×+22.5
2013Apr 12, 201319.1×−8.0
2012Dec 27, 201227.1×–

More BioRestorative Therapies figures

See a number that looks wrong?